Theratechnologies Inc
TSX:TH
Balance Sheet
Balance Sheet Decomposition
Theratechnologies Inc
Current Assets | 57.9m |
Cash & Short-Term Investments | 38.5m |
Receivables | 10.5m |
Other Current Assets | 9m |
Non-Current Assets | 14.1m |
PP&E | 1.8m |
Intangibles | 12.1m |
Other Non-Current Assets | 194k |
Current Liabilities | 50.3m |
Accounts Payable | 29.9m |
Other Current Liabilities | 20.4m |
Non-Current Liabilities | 46.4m |
Long-Term Debt | 46.4m |
Other Non-Current Liabilities | 22k |
Balance Sheet
Theratechnologies Inc
Nov-2014 | Nov-2015 | Nov-2016 | Nov-2017 | Nov-2018 | Nov-2019 | Nov-2020 | Nov-2021 | Nov-2022 | Nov-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
1
|
12
|
1
|
1
|
39
|
29
|
13
|
40
|
33
|
40
|
|
Cash |
1
|
12
|
1
|
1
|
39
|
29
|
13
|
20
|
24
|
34
|
|
Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
20
|
9
|
6
|
|
Short-Term Investments |
2
|
0
|
5
|
17
|
10
|
12
|
8
|
0
|
0
|
0
|
|
Total Receivables |
2
|
3
|
5
|
8
|
11
|
10
|
13
|
11
|
12
|
14
|
|
Accounts Receivables |
2
|
3
|
5
|
8
|
11
|
10
|
11
|
9
|
11
|
13
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
1
|
2
|
2
|
2
|
1
|
|
Inventory |
9
|
10
|
9
|
7
|
11
|
21
|
25
|
29
|
20
|
6
|
|
Other Current Assets |
1
|
1
|
1
|
2
|
3
|
5
|
6
|
11
|
8
|
3
|
|
Total Current Assets |
15
|
26
|
21
|
35
|
74
|
76
|
65
|
92
|
73
|
63
|
|
PP&E Net |
0
|
0
|
0
|
0
|
0
|
1
|
4
|
3
|
3
|
2
|
|
PP&E Gross |
0
|
0
|
0
|
0
|
0
|
1
|
4
|
3
|
3
|
2
|
|
Accumulated Depreciation |
2
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
|
Intangible Assets |
13
|
12
|
15
|
17
|
32
|
40
|
32
|
24
|
15
|
12
|
|
Long-Term Investments |
0
|
0
|
3
|
8
|
5
|
1
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
0
|
|
Total Assets |
29
N/A
|
38
+31%
|
39
+5%
|
59
+50%
|
111
+88%
|
118
+6%
|
100
-15%
|
119
+19%
|
93
-22%
|
78
-17%
|
|
Liabilities | |||||||||||
Accounts Payable |
2
|
2
|
2
|
5
|
26
|
13
|
18
|
16
|
13
|
7
|
|
Accrued Liabilities |
5
|
7
|
5
|
12
|
0
|
17
|
17
|
24
|
25
|
20
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
3
|
3
|
4
|
4
|
0
|
3
|
5
|
0
|
65
|
8
|
|
Other Current Liabilities |
1
|
1
|
1
|
2
|
1
|
3
|
3
|
5
|
11
|
13
|
|
Total Current Liabilities |
10
|
13
|
12
|
22
|
27
|
37
|
42
|
45
|
114
|
47
|
|
Long-Term Debt |
12
|
9
|
7
|
4
|
49
|
55
|
55
|
56
|
1
|
51
|
|
Other Liabilities |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Liabilities |
22
N/A
|
23
+4%
|
19
-14%
|
26
+32%
|
76
+196%
|
93
+22%
|
97
+5%
|
101
+5%
|
116
+14%
|
99
-15%
|
|
Equity | |||||||||||
Common Stock |
246
|
218
|
217
|
255
|
287
|
287
|
287
|
336
|
339
|
364
|
|
Retained Earnings |
247
|
210
|
209
|
233
|
265
|
278
|
300
|
335
|
383
|
409
|
|
Additional Paid In Capital |
7
|
6
|
11
|
12
|
9
|
11
|
12
|
13
|
19
|
23
|
|
Other Equity |
0
|
1
|
1
|
0
|
4
|
5
|
4
|
4
|
3
|
1
|
|
Total Equity |
7
N/A
|
15
+117%
|
20
+33%
|
33
+67%
|
35
+5%
|
25
-29%
|
3
-87%
|
18
+455%
|
23
N/A
|
21
+8%
|
|
Total Liabilities & Equity |
29
N/A
|
38
+31%
|
39
+5%
|
59
+50%
|
111
+88%
|
118
+6%
|
100
-15%
|
119
+19%
|
93
-22%
|
78
-17%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
61
|
66
|
66
|
75
|
77
|
77
|
77
|
24
|
24
|
46
|